Under the agreements, MSN Laboratory will establish a manufacturing unit along with a Research & Development (R&D) center. Laurus Labs and Aurobindo Pharma will set up formulation units. Gland Pharma has shown interest in opening an R&D center, as well as manufacturing units for injectables and drug substances. Dr. Reddy's Labs plans to establish a unit for injectables and biosimilars. Hetero Labs will set up a plant for finished dose and injectable manufacturing.
Minister KT Rama Rao said that “I am delighted that Gland Pharma will be investing Rs 400 Crores in expanding their footprint in Hyderabad and will create 500 more jobs in Telangana”
Hyderabad: Hyderabad-based Gland Pharma reported a 38 per cent increase in its net profit for the second quarter of FY22 ended September 30, 2021. The company also said it is on track to make four complex injectable filings in this financial year. Commenting on the results, Srinivas Sadu, MD & CEO of Gland Pharma said, […]
Karimnagar: Bala Vikasa Samithi, a non-governmental organisation, in association with Gland Pharma Limited donated seven ventilators to the district headquarters hospital in Karimnagar on Saturday. With the initiative of TS Planning Board Vice-Chairman B Vinod Kumar, the representatives of Gland Pharma handed over the ventilators to District Collector K Shashanka at his camp office here. […]
The company "will be leveraging its manufacturing capabilities for the production of Sputnik V COVID-19 vaccine," Gland Pharma said in a regulatory filing.
